Home >Participating Cliinical Centers >Boston University School Of Medicine Vasculitis Center

|
Boston University School Of Medicine Vasculitis Center |
Contact Information:
Peter Merkel, M.D., M.P.H.
Principal Investigator
Boston University School of Medicine Vasculitis Center
72 East Concord Street
Arthritis Center, E-5
Boston, MA 02118-3294
E-mail: pmerkel@bu.edu
Paul A. Monach, MD, PhD
Assistant Professor of Medicine
72 East Concord St. E-533
Boston, MA 02118
E-mail: pmonach@bu.edu
Tel: 617-414-2503
Carol McAlear, MA
Project Manager
Vasculitis Clinical Research Consortium (VCRC)
Boston University School of Medicine Vasculitis Center
72 East Concord Street
Boston, MA 02118
E-mail: caking@bu.edu
Tel: 617-414-2505
Fax: 617-414-2510
About Us:
The Boston University Vasculitis Center has an international reputation for the care of patients with vasculitis and research into these diseases. The Boston University Vasculitis Center has led or participated in all of the major U.S.-based multi centered clinical trials in vasculitis in the past ten years. Dr. Peter Merkel is the Director of the Boston University Vasculitis Center.
Current Studies:
5502: Longitudinal Protocol for Giant Cell Arteritis
5503: Longitudinal Protocol for Takayasu's Arteritis
5504: Longitudinal Protocol for Polyarteritis Nodosa
5505: Longitudinal Protocol for Wegener's Granulomatosis and Microscopic Polyangiitis
5506: Longitudinal Protocol for Churg-Strauss Syndrome
5515: VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-Vessel Vasculitis (Takayasu's Arteritis): Development as Clinical Trial Outcome Measures
5522: VCRC Multi-Center, Open-Label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener’s Granulomatosis (WG)
5523: Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu’s Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis (AGATA)
|